Products for Research Use Only
RegisterLogin

SPA-10091-HCl

CAT: 0957-E8279-1mgSize: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-E8279-1mgSize:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Target
DOT1
Applications
Epigenetics
Additionnal Information
SPA-10091-HCl is a degrader of DOT1L that selectively degrades DOT1L protein through the nuclear ubiquitin-proteasome pathway, thereby suppressing H3K79 methylation in CRPC cells. It also inhibits DOT1L enzymatic activity with an IC50 of 0.87 μM, induces apoptosis, and significantly reduces tumor growth in vivo.

Related Products

CatalogName
S4279-01Demeclocycline HCl
S4253-01Epinastine HCl
S4229-01Oxybuprocaine HCl
S4226-01Minocycline HCl
S4206-01Cysteamine HCl
S4202-01Verapamil HCl
S4200-01Tolperisone HCl
S4100-01Esmolol HCl
S4094-01Tetramisole HCl
S4070-01Guanidine HCl

Alternative Products

CatalogName
T207790-01SPA-10091-HCl
abx085369-01SPA-PEG-SPA
HO025025-6K-01SPA-PEG-SPA, 6K
HO025025-8K-01SPA-PEG-SPA, 8K
HO025025-500-01SPA-PEG-SPA, 500
HO025025-600-01SPA-PEG-SPA, 600
HO025025-400-01SPA-PEG-SPA, 400
HO025025-200-01SPA-PEG-SPA, 200
HO025025-800-01SPA-PEG-SPA, 800
HO025025-10K-01SPA-PEG-SPA, 10K

Popular Products